Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.320
-0.220 (-4.85%)
At close: Mar 6, 2026, 4:00 PM EST
4.650
+0.330 (7.64%)
After-hours: Mar 6, 2026, 4:35 PM EST
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $23.29 million as of March 6, 2026. Its market cap has increased by 162.47% in one year.
Market Cap
23.29M
Enterprise Value
1.15M
1-Year Change
162.47%
Ranking
Category
Stock Price
$4.32
Market Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $23.29M, an increase of 115.86%. That is a compound annual growth rate of 90.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 23.29M | 11.62% |
| Dec 31, 2025 | 20.86M | 273.80% |
| Dec 31, 2024 | 5.58M | -48.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AEON Biopharma | 26.63M |
| Hyperion DeFi | 26.54M |
| Evaxion | 25.85M |
| Boundless Bio | 25.63M |
| Passage Bio | 25.61M |
| Vistagen Therapeutics | 25.42M |
| Senti Biosciences | 25.19M |
| Lixte Biotechnology Holdings | 25.18M |